2022
DOI: 10.1186/s12890-022-01841-2
|View full text |Cite
|
Sign up to set email alerts
|

Application of POCUS in patients with COVID-19 for acute respiratory distress syndrome management: a narrative review

Abstract: COVID-19 has inflicted the world for over two years. The recent mutant virus strains pose greater challenges to disease prevention and treatment. COVID-19 can cause acute respiratory distress syndrome (ARDS) and extrapulmonary injury. Dynamic monitoring of each patient's condition is necessary to timely tailor treatments, improve prognosis and reduce mortality. Point-of-care ultrasound (POCUS) is broadly used in patients with ARDS. POCUS is recommended to be performed regularly in COVID-19 patients for respira… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 78 publications
0
11
0
Order By: Relevance
“…Shortly after, the patient suffered clinical deterioration with hypotension (90/40 mmHg), decrease of the oxygen saturation up to 80% with tachycardia and tachypnea requiring respiratory support with a face mask connected to the mechanical ventilator and vasopressors. Considering these sudden changes in patients hemodynamic status and taking into account COVID-19, increased thromboembolic risk [ 8 ], besides SARS CoV2 highly contagious nature which may limit patients access to diagnostic imaging due to hemodynamic instability or transfer difficulties [ 9 ]; an emergency focused transthoracic ultrasound echocardiography (FATE) was done, as one of multiple protocols of point-of-care ultrasound (POCUS), starting at the subcostal fourth chamber view and followed by the parasternal long-axis view [ 10 ]. The ultrasonographic remarkable findings were an impairment of the global systolic function with dilatation of the right ventricle and the presence of gas bubbles moving between right and left heart chambers (Additional file 1 : Video S1, Additional file 2 : Video S2, Additional file 3 : Video S3, Additional file 4 : Video S4, Additional file 5 : Video S5, Additional file 6 : Video S6).…”
Section: Case Reportmentioning
confidence: 99%
“…Shortly after, the patient suffered clinical deterioration with hypotension (90/40 mmHg), decrease of the oxygen saturation up to 80% with tachycardia and tachypnea requiring respiratory support with a face mask connected to the mechanical ventilator and vasopressors. Considering these sudden changes in patients hemodynamic status and taking into account COVID-19, increased thromboembolic risk [ 8 ], besides SARS CoV2 highly contagious nature which may limit patients access to diagnostic imaging due to hemodynamic instability or transfer difficulties [ 9 ]; an emergency focused transthoracic ultrasound echocardiography (FATE) was done, as one of multiple protocols of point-of-care ultrasound (POCUS), starting at the subcostal fourth chamber view and followed by the parasternal long-axis view [ 10 ]. The ultrasonographic remarkable findings were an impairment of the global systolic function with dilatation of the right ventricle and the presence of gas bubbles moving between right and left heart chambers (Additional file 1 : Video S1, Additional file 2 : Video S2, Additional file 3 : Video S3, Additional file 4 : Video S4, Additional file 5 : Video S5, Additional file 6 : Video S6).…”
Section: Case Reportmentioning
confidence: 99%
“…These findings add to the body of evidence in favor of the value of POCUS in assessing and managing patients with COVID-19 [ 17 - 20 ]. Among the several arguments for performing lung ultrasonography in the setting of COVID-19 infection, one is that lung ultrasound is performed at the bedside, by the treating clinician, without the need to move a potentially critically ill patient to the radiology suite [ 21 ].…”
Section: Discussionmentioning
confidence: 61%
“…Furthermore, we also provided the experience of using POCUS to manage COVID-19-related ARDS. [2] Significant progress in device technology and in the management of critically ill patients have allowed an international expansion of the use of VA ECMO. [3] However, short-term mortality remains high, with an overall survival rate of 40%, mainly due to the very high incidence of complications, among which infections are predominant.…”
Section: Introductionmentioning
confidence: 99%